×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IRD – opus genetics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IRD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/13
02:48 pm
ird
Update: Opus Genetics Shares Rise After Announcement of $25 Million Private Placement [Yahoo! Finance]
Low
Report
Update: Opus Genetics Shares Rise After Announcement of $25 Million Private Placement [Yahoo! Finance]
2/13
07:30 am
ird
Opus Genetics Announces $25 Million Private Placement
Medium
Report
Opus Genetics Announces $25 Million Private Placement
2/13
06:29 am
ird
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Medium
Report
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
2/2
08:00 am
ird
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
Low
Report
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
1/28
08:04 am
ird
Opus Genetics (NASDAQ:IRD) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $7.00 price target on the stock.
Medium
Report
Opus Genetics (NASDAQ:IRD) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $7.00 price target on the stock.
1/27
07:00 am
ird
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
Low
Report
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
1/21
06:19 am
ird
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Medium
Report
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
1/20
07:01 am
ird
Opus Genetics (NASDAQ:IRD) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
Medium
Report
Opus Genetics (NASDAQ:IRD) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/19
04:02 pm
ird
Form 8-K Opus Genetics, Inc. For: Feb 13
Medium
Report
Form 8-K Opus Genetics, Inc. For: Feb 13
2/17
05:14 pm
ird
Form 4 Opus Genetics, Inc. For: Feb 12 Filed by: Jayagopal Ashwath
Medium
Report
Form 4 Opus Genetics, Inc. For: Feb 12 Filed by: Jayagopal Ashwath
2/17
04:01 pm
ird
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
2/17
06:28 am
ird
Form SCHEDULE 13G Opus Genetics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Medium
Report
Form SCHEDULE 13G Opus Genetics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
2/13
05:06 pm
ird
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: Nantahala Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: Nantahala Capital Management, LLC
1/26
07:51 pm
ird
Form 4 Opus Genetics, Inc. For: Jan 22 Filed by: YERXA BENJAMIN R
Low
Report
Form 4 Opus Genetics, Inc. For: Jan 22 Filed by: YERXA BENJAMIN R
1/26
07:50 pm
ird
Form 4 Opus Genetics, Inc. For: Jan 22 Filed by: SCHACHLE JOSEPH K
Low
Report
Form 4 Opus Genetics, Inc. For: Jan 22 Filed by: SCHACHLE JOSEPH K
1/26
07:49 pm
ird
Form 4 Opus Genetics, Inc. For: Jan 22 Filed by: Zaremba Rabourn Amy
Low
Report
Form 4 Opus Genetics, Inc. For: Jan 22 Filed by: Zaremba Rabourn Amy
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: